Department of Materials Science and Technology, Graduate School of Science and Technology, Niigata University, Niigata 950-2181, Japan.
Department of Materials Science and Technology, Graduate School of Science and Technology, Niigata University, Niigata 950-2181, Japan.
J Biosci Bioeng. 2019 Aug;128(2):142-148. doi: 10.1016/j.jbiosc.2019.02.002. Epub 2019 Feb 21.
In our previous study, we identified multifunctional cationic peptides from enzymatic hydrolysates of rice bran proteins (RBPs) that have antimicrobial and lipopolysaccharide-neutralizing activities. In this study, we investigated the potential of the peptides RBP-LRR, RBP-EKL, and RBP-SSF to promote proliferation, angiogenesis (tube formation), and migration in human umbilical vein endothelial cells (HUVECs). To determine mechanisms of wound healing actions, angiogenic and migration-promoting activities of these peptides were evaluated following pretreatments of HUVECs with specific inhibitors. In these experiments, the cationic peptides RBP-LRR, RBP-EKL, and RBP-SSF induced cell proliferation at low concentrations of 0.1 μM or 1 μM. Moreover, the three cationic peptides had angiogenic activities at concentrations more than 1 μM in tube formation assays, and their effects were similar to those of LL-37. Subsequent scratch migration assays exhibited that RBP-LRR, RBP-EKL, and RBP-SSF promote wound closure at optimum concentrations of 10, 10, and 0.1 μM, respectively. In further studies, we performed tube formation assays using HUVECs pretreated with SU5416, which inhibits vascular endothelial growth factor (VEGF) receptors, and suggested the possibility that the three cationic peptides induce angiogenesis by activating VEGF receptors. In corresponding scratch migration assays using HUVECs, pretreatment with the proliferation inhibitor mitomycin C did not alter the effects of RBP-LRR and RBP-EKL, and significant contribution to wound closure were mediated by cell migration regardless of proliferation rates. In contrast, RBP-SSF contributed to wound closure exclusively by promoting cell proliferation. The present data indicate that RBP-LRR, RBP-EKL, and RBP-SSF are candidates for use as wound healing agents.
在我们之前的研究中,我们从米糠蛋白(RBPs)的酶解产物中鉴定出具有抗菌和脂多糖中和活性的多功能阳离子肽。在这项研究中,我们研究了肽 RBP-LRR、RBP-EKL 和 RBP-SSF 在促进人脐静脉内皮细胞(HUVECs)增殖、血管生成(管形成)和迁移方面的潜力。为了确定伤口愈合作用的机制,我们评估了这些肽在 HUVECs 用特定抑制剂预处理后对血管生成和迁移促进活性的影响。在这些实验中,阳离子肽 RBP-LRR、RBP-EKL 和 RBP-SSF 在低浓度 0.1μM 或 1μM 下诱导细胞增殖。此外,三种阳离子肽在管形成试验中浓度超过 1μM 时具有血管生成活性,其作用与 LL-37 相似。随后的划痕迁移试验表明,RBP-LRR、RBP-EKL 和 RBP-SSF 分别在最佳浓度 10、10 和 0.1μM 下促进伤口闭合。在进一步的研究中,我们使用预处理 SU5416 的 HUVEC 进行管形成试验,SU5416 抑制血管内皮生长因子(VEGF)受体,并表明这三种阳离子肽通过激活 VEGF 受体诱导血管生成的可能性。在使用 HUVEC 的相应划痕迁移试验中,用增殖抑制剂丝裂霉素 C 预处理不会改变 RBP-LRR 和 RBP-EKL 的作用,并且无论增殖率如何,细胞迁移对伤口闭合都有显著贡献。相比之下,RBP-SSF 仅通过促进细胞增殖来促进伤口闭合。本数据表明 RBP-LRR、RBP-EKL 和 RBP-SSF 是用作伤口愈合剂的候选物。